<DOC>
	<DOCNO>NCT02808351</DOCNO>
	<brief_summary>The number cardiac angiography percutaneous coronary intervention ( PCI ) increase steadily recent year . This result increase incidence contrast-induced nephropathy ( CIN ) . Major risk factor CIN include old age , diabetes mellitus ( DM ) , chronic kidney disease ( CKD ) , concurrent use nephrotoxic drug , hemodynamic instability , etc . Importantly , DM appear act risk multiplier , mean patient CKD amplifies risk CIAKI . The aim multicenter prospective , randomize , control study evaluate whether berberine treatment perioperative period would reduce risk CIN high-risk population patient DM CKD undergo coronary angiography noncoronary angiography , influence potential benefit short-term outcome .</brief_summary>
	<brief_title>Berberine Prevent Contrast-induced Nephropathy Patients With Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>Planned diagnostic coronary peripheral artery angiography Type 2 diabetes mellitus CKD stage ≥2 Statin naive , statin treatment least 14 day Withdrawal metformin aminophylline 48h angiography Total iodixanol volume Hypersensitivity iodinecontaining compound berberine Ketoacidosis Lactic acidosis CKD stag 1 , 5 ( eGFR≥90ml/min per 1.73m2 eGFR＜15ml/min per 1.73m2 ) STEMI NYHA class IV hemodynamic instability Administration iodinate contrast medium within 14 day randomization LDLC＜1.82mmol/L（70mg/dL） Hepatic dysfunction ( ALT 3 time great upper normal limit ) Thyreoid insufficiency Renal artery Stenosis ( unilateral ＞70％ bilateral stenosis＞50％ )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>